Life Sciences Insights

We Turn Industry Insight into Shared Knowledge

Insights, perspectives, and stories from across California’s life sciences community.

The Latest CLS Insights

CLS

Where Progress Lives: This Month in California Life Sciences May 2026

CLS

Where Progress Lives: This Month in California Life Sciences April 2026

CLSEvents

Rising healthcare costs and AI transformation: Beyond the Tipping Point

Search

Search
Categories
  • Member Voice (42)
  • CLS (5)
  • Industry (5)
  • Events (1)
Contributors
  • Abalone Bio (1)
  • AstraZeneca (1)
  • Avance Clinical (1)
  • Battelle (1)
  • Biointron (1)
  • Biotech Connection LA (1)
  • Boehringer Ingelheim USA (1)
  • Centogene (4)
  • CleanSpace (3)
  • Digital Science (2)
  • Eppendorf (1)
  • Fenix Group (1)
  • Flannery Sales Systems (1)
  • Germfree (1)
  • Grace Lillie (1)
  • Hogan Lovells (1)
  • Katalyze AI (1)
  • Life Science Nation (1)
  • MabPlex (2)
  • MBC BioLabs (1)
  • Medscape Education (1)
  • Mike Guerra (3)
  • Oncotelic (1)
  • Origami Therapeutics (1)
  • Procopio (1)
  • Royale International (7)
  • SankerIP (1)
  • Withum (1)
CLS

Where Progress Lives: This Month in California Life Sciences May 2026

Mike Guerra

Each month, California Life Sciences (CLS) President and CEO Mike Guerra shares what’s shaping the life sciences industry, highlights the...

CLS

Where Progress Lives: This Month in California Life Sciences April 2026

Mike Guerra

Table of Contents California’s ecosystem: extraordinary by design Policy Progress in Washington D.C. Building a stronger, more connected life sciences...

CLS Events

Rising healthcare costs and AI transformation: Beyond the Tipping Point

Rising healthcare costs and AI-driven workforce transformation are two of the most pressing issues facing employers today. On April 8...

CLS

Meet the FAST Spring 2026 Cohort

Meet the 12 companies joining FAST California’s Spring 2026 cohort — spanning neuroscience, oncology, rare disease, medical devices, and digital...

CLS

Where Progress Lives – March 2026

Mike Guerra

Nearly $6 billion in frozen funding freed. AI factories launched. A pediatric cancer breakthrough acquired. CLS President & CEO Mike...